A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of Relapse

Clinical trial NCT02364492 · COMPLETED

Trial details

NCT number: NCT02364492
Sponsor: Institut Pasteur
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2015-02-01
Primary completion: 2019-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.